糖尿病性ニューロパチーの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Diabetic Neuropathy Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8101684)・商品コード:GIR8101684
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年8月28日
・ページ数:134
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、糖尿病性ニューロパチーの世界市場について調べ、まとめました。種類別セグメントは、末梢神経障害、自律神経障害、近位神経障害、焦点神経障害等、用途別セグメントは、病院、診療所、小売薬局、ンライン薬局等に区分しました。糖尿病性ニューロパチーの世界市場概観、メーカー動向、メーカー別糖尿病性ニューロパチーシェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・糖尿病性ニューロパチーの市場概観
・糖尿病性ニューロパチーのメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・糖尿病性ニューロパチーのメーカー別販売動向、市場シェア、市場集中度、競争動向
・糖尿病性ニューロパチーの世界市場規模
・糖尿病性ニューロパチーの北米市場分析(アメリカ、カナダ、メキシコ等)
・糖尿病性ニューロパチーのアメリカ市場規模推移
・糖尿病性ニューロパチーのカナダ市場規模推移
・糖尿病性ニューロパチーのメキシコ市場規模推移
・糖尿病性ニューロパチーのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・糖尿病性ニューロパチーのドイツ市場規模推移
・糖尿病性ニューロパチーのイギリス市場規模推移
・糖尿病性ニューロパチーのロシア市場規模推移
・糖尿病性ニューロパチーのアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・糖尿病性ニューロパチーの日本市場規模推移
・糖尿病性ニューロパチーの中国市場規模推移
・糖尿病性ニューロパチーの韓国市場規模推移
・糖尿病性ニューロパチーのインド市場規模推移
・糖尿病性ニューロパチーの東南アジア市場規模推移
・糖尿病性ニューロパチーの南米市場分析(ブラジル、アルゼンチン等)
・糖尿病性ニューロパチーの中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・糖尿病性ニューロパチーの種類別分析/市場規模推移(末梢神経障害、自律神経障害、近位神経障害、焦点神経障害)
・糖尿病性ニューロパチーの用途別分析/市場規模推移(病院、診療所、小売薬局、ンライン薬局)
・糖尿病性ニューロパチーの市場予測(地域別予測、種類別予測、用途別予測)
・糖尿病性ニューロパチーの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Growth in global diabetic neuropathy market is highly attributed to consistently increasing diabetic population across the globe linked with growing awareness among people is considered as major market driver for diabetic neuropathy market. Moreover, global market is primarily driven by changing lifestyle which has mostly resulted into unhealthy dietary habits and patterns. In addition, factors such as increasing aging population, rise in healthcare expenditure for diabetes, growing awareness about diabetes, and rise in R&D activities in drug discovery and development have contributed in the global growth. However, growth of this market is predominantly restrained by longer approval time for drugs and side effects and rising cost of diabetic neuropathy treatment. Also, stringent regulatory requirement and significant failure rate during the clinical trials expected to be the growth barriers in the years to come.

Scope of the Report:

This report focuses on the Diabetic Neuropathy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Diabetic Neuropathy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Pfizer Inc

Janssen Pharmaceuticals, Inc

Eli Lilly and Company

ACTAVIS

Cephalon Inc

MEDA Pharma GmBH & Co. KG

GlaxoSmithKline

NeuroMetrix

Johnson and Johnson

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Peripheral Neuropathy

Autonomic Neuropathy

Proximal Neuropathy

Focal Neuropathy

Market Segment by Applications, can be divided into

Hospitals

Clinics

Retail Pharmacy

Online Pharmacy

There are 15 Chapters to deeply display the global Diabetic Neuropathy market.

Chapter 1, to describe Diabetic Neuropathy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Diabetic Neuropathy, with sales, revenue, and price of Diabetic Neuropathy, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Diabetic Neuropathy, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Diabetic Neuropathy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Diabetic Neuropathy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents

1 Market Overview

1.1 Diabetic Neuropathy Introduction

1.2 Market Analysis by Type

1.2.1 Peripheral Neuropathy

1.2.2 Autonomic Neuropathy

1.2.3 Proximal Neuropathy

1.2.4 Focal Neuropathy

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Clinics

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer Inc

2.1.1 Business Overview

2.1.2 Diabetic Neuropathy Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Inc Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Janssen Pharmaceuticals, Inc

2.2.1 Business Overview

2.2.2 Diabetic Neuropathy Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Janssen Pharmaceuticals, Inc Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Eli Lilly and Company

2.3.1 Business Overview

2.3.2 Diabetic Neuropathy Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly and Company Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 ACTAVIS

2.4.1 Business Overview

2.4.2 Diabetic Neuropathy Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 ACTAVIS Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Cephalon Inc

2.5.1 Business Overview

2.5.2 Diabetic Neuropathy Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Cephalon Inc Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 MEDA Pharma GmBH & Co. KG

2.6.1 Business Overview

2.6.2 Diabetic Neuropathy Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 MEDA Pharma GmBH & Co. KG Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 GlaxoSmithKline

2.7.1 Business Overview

2.7.2 Diabetic Neuropathy Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 GlaxoSmithKline Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 NeuroMetrix

2.8.1 Business Overview

2.8.2 Diabetic Neuropathy Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 NeuroMetrix Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Johnson and Johnson

2.9.1 Business Overview

2.9.2 Diabetic Neuropathy Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Johnson and Johnson Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Diabetic Neuropathy Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Diabetic Neuropathy Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Diabetic Neuropathy Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Diabetic Neuropathy Manufacturer Market Share in 2017

3.3.2 Top 6 Diabetic Neuropathy Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Diabetic Neuropathy Market Analysis by Regions

4.1 Global Diabetic Neuropathy Sales, Revenue and Market Share by Regions

4.1.1 Global Diabetic Neuropathy Sales and Market Share by Regions (2013-2018)

4.1.2 Global Diabetic Neuropathy Revenue and Market Share by Regions (2013-2018)

4.2 North America Diabetic Neuropathy Sales and Growth Rate (2013-2018)

4.3 Europe Diabetic Neuropathy Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Diabetic Neuropathy Sales and Growth Rate (2013-2018)

4.5 South America Diabetic Neuropathy Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Diabetic Neuropathy Sales and Growth Rate (2013-2018)

5 North America Diabetic Neuropathy by Countries

5.1 North America Diabetic Neuropathy Sales, Revenue and Market Share by Countries

5.1.1 North America Diabetic Neuropathy Sales and Market Share by Countries (2013-2018)

5.1.2 North America Diabetic Neuropathy Revenue and Market Share by Countries (2013-2018)

5.2 United States Diabetic Neuropathy Sales and Growth Rate (2013-2018)

5.3 Canada Diabetic Neuropathy Sales and Growth Rate (2013-2018)

5.4 Mexico Diabetic Neuropathy Sales and Growth Rate (2013-2018)

6 Europe Diabetic Neuropathy by Countries

6.1 Europe Diabetic Neuropathy Sales, Revenue and Market Share by Countries

6.1.1 Europe Diabetic Neuropathy Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Diabetic Neuropathy Revenue and Market Share by Countries (2013-2018)

6.2 Germany Diabetic Neuropathy Sales and Growth Rate (2013-2018)

6.3 UK Diabetic Neuropathy Sales and Growth Rate (2013-2018)

6.4 France Diabetic Neuropathy Sales and Growth Rate (2013-2018)

6.5 Russia Diabetic Neuropathy Sales and Growth Rate (2013-2018)

6.6 Italy Diabetic Neuropathy Sales and Growth Rate (2013-2018)

7 Asia-Pacific Diabetic Neuropathy by Countries

7.1 Asia-Pacific Diabetic Neuropathy Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Diabetic Neuropathy Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Diabetic Neuropathy Revenue and Market Share by Countries (2013-2018)

7.2 China Diabetic Neuropathy Sales and Growth Rate (2013-2018)

7.3 Japan Diabetic Neuropathy Sales and Growth Rate (2013-2018)

7.4 Korea Diabetic Neuropathy Sales and Growth Rate (2013-2018)

7.5 India Diabetic Neuropathy Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Diabetic Neuropathy Sales and Growth Rate (2013-2018)

8 South America Diabetic Neuropathy by Countries

8.1 South America Diabetic Neuropathy Sales, Revenue and Market Share by Countries

8.1.1 South America Diabetic Neuropathy Sales and Market Share by Countries (2013-2018)

8.1.2 South America Diabetic Neuropathy Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Diabetic Neuropathy Sales and Growth Rate (2013-2018)

8.3 Argentina Diabetic Neuropathy Sales and Growth Rate (2013-2018)

8.4 Colombia Diabetic Neuropathy Sales and Growth Rate (2013-2018)

9 Middle East and Africa Diabetic Neuropathy by Countries

9.1 Middle East and Africa Diabetic Neuropathy Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Diabetic Neuropathy Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Diabetic Neuropathy Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Diabetic Neuropathy Sales and Growth Rate (2013-2018)

9.3 UAE Diabetic Neuropathy Sales and Growth Rate (2013-2018)

9.4 Egypt Diabetic Neuropathy Sales and Growth Rate (2013-2018)

9.5 Nigeria Diabetic Neuropathy Sales and Growth Rate (2013-2018)

9.6 South Africa Diabetic Neuropathy Sales and Growth Rate (2013-2018)

10 Global Diabetic Neuropathy Market Segment by Type

10.1 Global Diabetic Neuropathy Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Diabetic Neuropathy Sales and Market Share by Type (2013-2018)

10.1.2 Global Diabetic Neuropathy Revenue and Market Share by Type (2013-2018)

10.2 Peripheral Neuropathy Sales Growth and Price

10.2.1 Global Peripheral Neuropathy Sales Growth (2013-2018)

10.2.2 Global Peripheral Neuropathy Price (2013-2018)

10.3 Autonomic Neuropathy Sales Growth and Price

10.3.1 Global Autonomic Neuropathy Sales Growth (2013-2018)

10.3.2 Global Autonomic Neuropathy Price (2013-2018)

10.4 Proximal Neuropathy Sales Growth and Price

10.4.1 Global Proximal Neuropathy Sales Growth (2013-2018)

10.4.2 Global Proximal Neuropathy Price (2013-2018)

10.5 Focal Neuropathy Sales Growth and Price

10.5.1 Global Focal Neuropathy Sales Growth (2013-2018)

10.5.2 Global Focal Neuropathy Price (2013-2018)

11 Global Diabetic Neuropathy Market Segment by Application

11.1 Global Diabetic Neuropathy Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Clinics Sales Growth (2013-2018)

11.4 Retail Pharmacy Sales Growth (2013-2018)

11.5 Online Pharmacy Sales Growth (2013-2018)

12 Diabetic Neuropathy Market Forecast (2018-2023)

12.1 Global Diabetic Neuropathy Sales, Revenue and Growth Rate (2018-2023)

12.2 Diabetic Neuropathy Market Forecast by Regions (2018-2023)

12.2.1 North America Diabetic Neuropathy Market Forecast (2018-2023)

12.2.2 Europe Diabetic Neuropathy Market Forecast (2018-2023)

12.2.3 Asia-Pacific Diabetic Neuropathy Market Forecast (2018-2023)

12.2.4 South America Diabetic Neuropathy Market Forecast (2018-2023)

12.2.5 Middle East and Africa Diabetic Neuropathy Market Forecast (2018-2023)

12.3 Diabetic Neuropathy Market Forecast by Type (2018-2023)

12.3.1 Global Diabetic Neuropathy Sales Forecast by Type (2018-2023)

12.3.2 Global Diabetic Neuropathy Market Share Forecast by Type (2018-2023)

12.4 Diabetic Neuropathy Market Forecast by Application (2018-2023)

12.4.1 Global Diabetic Neuropathy Sales Forecast by Application (2018-2023)

12.4.2 Global Diabetic Neuropathy Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures



Figure Diabetic Neuropathy Picture

Table Product Specifications of Diabetic Neuropathy

Figure Global Sales Market Share of Diabetic Neuropathy by Types in 2017

Table Diabetic Neuropathy Types for Major Manufacturers

Figure Peripheral Neuropathy Picture

Figure Autonomic Neuropathy Picture

Figure Proximal Neuropathy Picture

Figure Focal Neuropathy Picture

Figure Diabetic Neuropathy Sales Market Share by Applications in 2017

Figure Hospitals Picture

Figure Clinics Picture

Figure Retail Pharmacy Picture

Figure Online Pharmacy Picture

Figure United States Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure France Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure UK Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure China Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure India Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Diabetic Neuropathy Revenue (Value) and Growth Rate (2013-2023)

Table Pfizer Inc Basic Information, Manufacturing Base and Competitors

Table Pfizer Inc Diabetic Neuropathy Type and Applications

Table Pfizer Inc Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Janssen Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors

Table Janssen Pharmaceuticals, Inc Diabetic Neuropathy Type and Applications

Table Janssen Pharmaceuticals, Inc Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors

Table Eli Lilly and Company Diabetic Neuropathy Type and Applications

Table Eli Lilly and Company Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table ACTAVIS Basic Information, Manufacturing Base and Competitors

Table ACTAVIS Diabetic Neuropathy Type and Applications

Table ACTAVIS Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Cephalon Inc Basic Information, Manufacturing Base and Competitors

Table Cephalon Inc Diabetic Neuropathy Type and Applications

Table Cephalon Inc Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table MEDA Pharma GmBH & Co. KG Basic Information, Manufacturing Base and Competitors

Table MEDA Pharma GmBH & Co. KG Diabetic Neuropathy Type and Applications

Table MEDA Pharma GmBH & Co. KG Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Diabetic Neuropathy Type and Applications

Table GlaxoSmithKline Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table NeuroMetrix Basic Information, Manufacturing Base and Competitors

Table NeuroMetrix Diabetic Neuropathy Type and Applications

Table NeuroMetrix Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson and Johnson Diabetic Neuropathy Type and Applications

Table Johnson and Johnson Diabetic Neuropathy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Diabetic Neuropathy Sales by Manufacturer (2016-2017)

Figure Global Diabetic Neuropathy Sales Market Share by Manufacturer in 2016

Figure Global Diabetic Neuropathy Sales Market Share by Manufacturer in 2017

Table Global Diabetic Neuropathy Revenue by Manufacturer (2016-2017)

Figure Global Diabetic Neuropathy Revenue Market Share by Manufacturer in 2016

Figure Global Diabetic Neuropathy Revenue Market Share by Manufacturer in 2017

Figure Top 3 Diabetic Neuropathy Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Diabetic Neuropathy Manufacturer (Revenue) Market Share in 2017

Figure Global Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Global Diabetic Neuropathy Revenue and Growth Rate (2013-2018)

Table Global Diabetic Neuropathy Sales by Regions (2013-2018)

Table Global Diabetic Neuropathy Sales Market Share by Regions (2013-2018)

Table Global Diabetic Neuropathy Revenue by Regions (2013-2018)

Figure Global Diabetic Neuropathy Revenue Market Share by Regions in 2013

Figure Global Diabetic Neuropathy Revenue Market Share by Regions in 2017

Figure North America Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Europe Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure South America Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure North America Diabetic Neuropathy Revenue and Growth Rate (2013-2018)

Table North America Diabetic Neuropathy Sales by Countries (2013-2018)

Table North America Diabetic Neuropathy Sales Market Share by Countries (2013-2018)

Figure North America Diabetic Neuropathy Sales Market Share by Countries in 2013

Figure North America Diabetic Neuropathy Sales Market Share by Countries in 2017

Table North America Diabetic Neuropathy Revenue by Countries (2013-2018)

Table North America Diabetic Neuropathy Revenue Market Share by Countries (2013-2018)

Figure North America Diabetic Neuropathy Revenue Market Share by Countries in 2013

Figure North America Diabetic Neuropathy Revenue Market Share by Countries in 2017

Figure United States Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Canada Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Mexico Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Europe Diabetic Neuropathy Revenue and Growth Rate (2013-2018)

Table Europe Diabetic Neuropathy Sales by Countries (2013-2018)

Table Europe Diabetic Neuropathy Sales Market Share by Countries (2013-2018)

Table Europe Diabetic Neuropathy Revenue by Countries (2013-2018)

Figure Europe Diabetic Neuropathy Revenue Market Share by Countries in 2016

Figure Europe Diabetic Neuropathy Revenue Market Share by Countries in 2017

Figure Germany Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure UK Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure France Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Russia Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Italy Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Diabetic Neuropathy Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Diabetic Neuropathy Sales by Countries (2013-2018)

Table Asia-Pacific Diabetic Neuropathy Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Diabetic Neuropathy Sales Market Share by Countries 2017

Table Asia-Pacific Diabetic Neuropathy Revenue by Countries (2013-2018)

Figure Asia-Pacific Diabetic Neuropathy Revenue Market Share by Countries 2017

Figure China Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Japan Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Korea Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure India Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Southeast Asia Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure South America Diabetic Neuropathy Revenue and Growth Rate (2013-2018)

Table South America Diabetic Neuropathy Sales by Countries (2013-2018)

Table South America Diabetic Neuropathy Sales Market Share by Countries (2013-2018)

Figure South America Diabetic Neuropathy Sales Market Share by Countries in 2017

Table South America Diabetic Neuropathy Revenue by Countries (2013-2018)

Table South America Diabetic Neuropathy Revenue Market Share by Countries (2013-2018)

Figure South America Diabetic Neuropathy Revenue Market Share by Countries in 2017

Figure Brazil Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Argentina Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Colombia Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Diabetic Neuropathy Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Diabetic Neuropathy Sales by Countries (2013-2018)

Table Middle East and Africa Diabetic Neuropathy Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Diabetic Neuropathy Sales Market Share by Countries in 2017

Table Middle East and Africa Diabetic Neuropathy Revenue by Countries (2013-2018)

Table Middle East and Africa Diabetic Neuropathy Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Diabetic Neuropathy Revenue Market Share by Countries in 2013

Figure Middle East and Africa Diabetic Neuropathy Revenue Market Share by Countries in 2017

Figure Saudi Arabia Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure UAE Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Egypt Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure Nigeria Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Figure South Africa Diabetic Neuropathy Sales and Growth Rate (2013-2018)

Table Global Diabetic Neuropathy Sales by Type (2013-2018)

Table Global Diabetic Neuropathy Sales Share by Type (2013-2018)

Table Global Diabetic Neuropathy Revenue by Type (2013-2018)

Table Global Diabetic Neuropathy Revenue Share by Type (2013-2018)

Figure Global Peripheral Neuropathy Sales Growth (2013-2018)

Figure Global Peripheral Neuropathy Price (2013-2018)

Figure Global Autonomic Neuropathy Sales Growth (2013-2018)

Figure Global Autonomic Neuropathy Price (2013-2018)

Figure Global Proximal Neuropathy Sales Growth (2013-2018)

Figure Global Proximal Neuropathy Price (2013-2018)

Figure Global Focal Neuropathy Sales Growth (2013-2018)

Figure Global Focal Neuropathy Price (2013-2018)

Table Global Diabetic Neuropathy Sales by Application (2013-2018)

Table Global Diabetic Neuropathy Sales Share by Application (2013-2018)

Figure Global Clinics Sales Growth (2013-2018)

Figure Global Retail Pharmacy Sales Growth (2013-2018)

Figure Global Online Pharmacy Sales Growth (2013-2018)

Figure Global Diabetic Neuropathy Sales, Revenue and Growth Rate (2018-2023)

Table Global Diabetic Neuropathy Sales Forecast by Regions (2018-2023)

Table Global Diabetic Neuropathy Market Share Forecast by Regions (2018-2023)

Figure North America Sales Diabetic Neuropathy Market Forecast (2018-2023)

Figure Europe Sales Diabetic Neuropathy Market Forecast (2018-2023)

Figure Asia-Pacific Sales Diabetic Neuropathy Market Forecast (2018-2023)

Figure South America Sales Diabetic Neuropathy Market Forecast (2018-2023)

Figure Middle East and Africa Sales Diabetic Neuropathy Market Forecast (2018-2023)

Table Global Diabetic Neuropathy Sales Forecast by Type (2018-2023)

Table Global Diabetic Neuropathy Market Share Forecast by Type (2018-2023)

Table Global Diabetic Neuropathy Sales Forecast by Application (2018-2023)

Table Global Diabetic Neuropathy Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List



【レポートのキーワード】

糖尿病性ニューロパチー、末梢神経障害、自律神経障害、近位神経障害、焦点神経障害、病院、診療所、小売薬局、ンライン薬局

★調査レポート[糖尿病性ニューロパチーの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8101684)販売に関する免責事項を必ずご確認ください。
★調査レポート[糖尿病性ニューロパチーの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆